
Newron Pharmaceuticals SpA
SIX:NWRN

Intrinsic Value
The intrinsic value of one
NWRN
stock under the Base Case scenario is
hidden
CHF.
Compared to the current market price of 6.03 CHF,
Newron Pharmaceuticals SpA
is
hidden
.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
Newron Pharmaceuticals SpA
Fundamental Analysis


Revenue & Expenses Breakdown
Newron Pharmaceuticals SpA
Balance Sheet Decomposition
Newron Pharmaceuticals SpA
Current Assets | 61.1m |
Cash & Short-Term Investments | 9.8m |
Receivables | 47.1m |
Other Current Assets | 4.2m |
Non-Current Assets | 2.8m |
PP&E | 834k |
Other Non-Current Assets | 2m |
Free Cash Flow Analysis
Newron Pharmaceuticals SpA
EUR | |
Free Cash Flow | EUR |
Earnings Waterfall
Newron Pharmaceuticals SpA
Revenue
|
51.4m
EUR
|
Cost of Revenue
|
-892k
EUR
|
Gross Profit
|
50.5m
EUR
|
Operating Expenses
|
-24.3m
EUR
|
Operating Income
|
26.2m
EUR
|
Other Expenses
|
-10.3m
EUR
|
Net Income
|
15.8m
EUR
|
NWRN Profitability Score
Profitability Due Diligence
Newron Pharmaceuticals SpA's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Score
Newron Pharmaceuticals SpA's profitability score is hidden . The higher the profitability score, the more profitable the company is.
NWRN Solvency Score
Solvency Due Diligence
Newron Pharmaceuticals SpA's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Score
Newron Pharmaceuticals SpA's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
NWRN Price Targets Summary
Newron Pharmaceuticals SpA
According to Wall Street analysts, the average 1-year price target for
NWRN
is 16.76 CHF
with a low forecast of 11.62 CHF and a high forecast of 26.25 CHF.
Dividends
Current shareholder yield for NWRN is
hidden
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
NWRN
stock under the Base Case scenario is
hidden
CHF.
Compared to the current market price of 6.03 CHF,
Newron Pharmaceuticals SpA
is
hidden
.